Friday, December 29, 2017

FDA Closing Statement on Gardasil

The 2008 FDA Closing Statement on Gardasil reports that 73.3% of the ‘healthy’ girls who participated in the clinical trials developed new medical conditions. The list below highlights some of the conditions reported in the 2008 FDA Closing Statement on Gardasil:
◦Blood & Lymphatic System Disorders 2.9% = 1 in 34
◦Gastrointestinal Disorders 13.4% = 1 in 7
◦General & Administration Site Conditions 3.8% = 1 in 33
◦Immune System Disorders 2.4% =1 in 50
◦Infections & Infestations 52.9% = 1 in 2
◦Injury, Poisoning, & Procedural Complications 8.0% =1 in 12
◦Investigations 11.8% =1 in 9
◦Musculoskeletal & Connective Tissue Disorders 6.8% =1 in 14
◦Nervous System Disorders 9.4% = 1 in 10
◦Pregnancy, Puerperium & Perinatal Conditions 2.0% = 1 in 50
◦Psychiatric Disorders 4.4% =1 in 22
◦Renal Disorders 2.7% =1 in 37
◦Reproductive & Brest Disorders 24.8 % = 1 in 14
◦Respiratory, Thoracic & Mediastinal Disorders 5.5% = 1 in 18
◦Skin & Subcutaneous Tissue Disorders 7.4% = 1 in 13
◦Surgical Procedures = Appendectomy 10.2% = 1 in 10
https://holyhormones.com/2008-fda-closing-statement-on-gardasil/

No comments: